Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 13 | 2023 | 1684 | 3.590 |
Why?
|
Postmenopause | 7 | 2020 | 2423 | 2.030 |
Why?
|
Sleep | 13 | 2023 | 4184 | 1.780 |
Why?
|
Ovarian Neoplasms | 10 | 2021 | 4748 | 1.510 |
Why?
|
Ovulation | 2 | 2020 | 182 | 1.470 |
Why?
|
Neoplasms, Glandular and Epithelial | 4 | 2016 | 509 | 1.310 |
Why?
|
Adiposity | 5 | 2019 | 1763 | 1.230 |
Why?
|
Hyperglycemia | 3 | 2022 | 1354 | 1.080 |
Why?
|
Parity | 2 | 2019 | 891 | 1.060 |
Why?
|
Spinal Fractures | 2 | 2022 | 691 | 1.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2021 | 927 | 1.010 |
Why?
|
Premenopause | 2 | 2020 | 1023 | 0.980 |
Why?
|
Hip Fractures | 2 | 2022 | 885 | 0.950 |
Why?
|
Receptors, Leptin | 4 | 2019 | 341 | 0.880 |
Why?
|
Ovarian Function Tests | 1 | 2020 | 12 | 0.810 |
Why?
|
Actigraphy | 4 | 2021 | 447 | 0.790 |
Why?
|
Phthalic Acids | 5 | 2016 | 400 | 0.770 |
Why?
|
Dehydroepiandrosterone | 2 | 2019 | 246 | 0.760 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2055 | 0.700 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 246 | 0.700 |
Why?
|
Nurses | 4 | 2023 | 2391 | 0.680 |
Why?
|
Diet, Vegetarian | 1 | 2019 | 173 | 0.640 |
Why?
|
Contraceptives, Oral | 1 | 2019 | 555 | 0.620 |
Why?
|
Adipokines | 2 | 2016 | 310 | 0.610 |
Why?
|
Body Mass Index | 14 | 2022 | 12547 | 0.610 |
Why?
|
Prospective Studies | 25 | 2023 | 51354 | 0.610 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2020 | 11098 | 0.580 |
Why?
|
Amino Acids | 2 | 2022 | 1712 | 0.550 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2016 | 209 | 0.550 |
Why?
|
Risk Factors | 31 | 2023 | 70931 | 0.540 |
Why?
|
Obesity | 8 | 2023 | 12268 | 0.540 |
Why?
|
Ovary | 1 | 2019 | 999 | 0.530 |
Why?
|
Diet | 5 | 2022 | 7647 | 0.530 |
Why?
|
Self Report | 4 | 2023 | 3409 | 0.520 |
Why?
|
Atherosclerosis | 5 | 2023 | 3159 | 0.520 |
Why?
|
Depression | 7 | 2022 | 7266 | 0.500 |
Why?
|
Environmental Pollutants | 4 | 2016 | 1036 | 0.500 |
Why?
|
C-Reactive Protein | 3 | 2021 | 3725 | 0.490 |
Why?
|
Menopause | 3 | 2018 | 1536 | 0.490 |
Why?
|
Follow-Up Studies | 15 | 2022 | 39334 | 0.490 |
Why?
|
Child Abuse | 1 | 2022 | 988 | 0.480 |
Why?
|
Cross-Sectional Studies | 16 | 2023 | 23385 | 0.480 |
Why?
|
Hydrocortisone | 2 | 2019 | 1734 | 0.480 |
Why?
|
Pregnancy in Diabetics | 1 | 2014 | 188 | 0.480 |
Why?
|
Female | 57 | 2023 | 377052 | 0.470 |
Why?
|
Postpartum Period | 3 | 2017 | 985 | 0.460 |
Why?
|
Pregnancy Complications | 3 | 2017 | 2838 | 0.460 |
Why?
|
Longevity | 1 | 2020 | 1031 | 0.450 |
Why?
|
Blood Glucose | 6 | 2022 | 6253 | 0.450 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 337 | 0.450 |
Why?
|
Metabolic Diseases | 1 | 2019 | 649 | 0.450 |
Why?
|
Hypertension | 4 | 2021 | 8270 | 0.440 |
Why?
|
Circadian Rhythm | 3 | 2021 | 2546 | 0.430 |
Why?
|
Middle Aged | 38 | 2023 | 214639 | 0.420 |
Why?
|
Coronary Disease | 4 | 2022 | 6162 | 0.420 |
Why?
|
Endocrine Disruptors | 1 | 2014 | 198 | 0.410 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 386 | 0.410 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1939 | 0.400 |
Why?
|
Inflammation | 5 | 2022 | 10090 | 0.400 |
Why?
|
Humans | 66 | 2023 | 715594 | 0.370 |
Why?
|
Insulin | 7 | 2022 | 6654 | 0.360 |
Why?
|
Incidence | 8 | 2022 | 20761 | 0.360 |
Why?
|
Sex Factors | 3 | 2019 | 10660 | 0.350 |
Why?
|
Adult | 33 | 2022 | 212237 | 0.350 |
Why?
|
Adiponectin | 4 | 2019 | 1091 | 0.350 |
Why?
|
Insulin Resistance | 1 | 2022 | 3891 | 0.350 |
Why?
|
Cardiovascular Diseases | 8 | 2023 | 14439 | 0.330 |
Why?
|
Adipose Tissue | 2 | 2016 | 3229 | 0.310 |
Why?
|
Leptin | 4 | 2019 | 1574 | 0.310 |
Why?
|
Age Factors | 3 | 2020 | 18772 | 0.300 |
Why?
|
Time Factors | 8 | 2021 | 40889 | 0.290 |
Why?
|
Sleep Deprivation | 3 | 2023 | 810 | 0.280 |
Why?
|
Saliva | 3 | 2019 | 800 | 0.280 |
Why?
|
Motor Activity | 1 | 2015 | 2774 | 0.270 |
Why?
|
Stress, Psychological | 2 | 2022 | 4165 | 0.260 |
Why?
|
Health Surveys | 4 | 2020 | 4030 | 0.260 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2019 | 661 | 0.260 |
Why?
|
Aged | 23 | 2023 | 162392 | 0.260 |
Why?
|
Overweight | 2 | 2017 | 2262 | 0.260 |
Why?
|
United States | 15 | 2023 | 67895 | 0.240 |
Why?
|
Feeding Behavior | 1 | 2016 | 3193 | 0.240 |
Why?
|
Noise, Transportation | 1 | 2023 | 51 | 0.230 |
Why?
|
Longitudinal Studies | 6 | 2022 | 13635 | 0.220 |
Why?
|
Metabolomics | 2 | 2021 | 1388 | 0.220 |
Why?
|
Aging | 2 | 2021 | 8352 | 0.210 |
Why?
|
Life Style | 4 | 2022 | 3747 | 0.210 |
Why?
|
Fasting | 2 | 2019 | 1592 | 0.200 |
Why?
|
Snoring | 1 | 2022 | 180 | 0.200 |
Why?
|
Lipids | 3 | 2022 | 3247 | 0.190 |
Why?
|
Ownership | 1 | 2022 | 324 | 0.190 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3359 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8560 | 0.190 |
Why?
|
Polysomnography | 3 | 2021 | 1708 | 0.190 |
Why?
|
C-Peptide | 2 | 2018 | 411 | 0.190 |
Why?
|
Comorbidity | 3 | 2020 | 10429 | 0.180 |
Why?
|
Basal Metabolism | 1 | 2020 | 164 | 0.180 |
Why?
|
Prevalence | 4 | 2019 | 14877 | 0.170 |
Why?
|
Proportional Hazards Models | 4 | 2018 | 12495 | 0.170 |
Why?
|
Calcium Channel Blockers | 1 | 2021 | 698 | 0.170 |
Why?
|
Interleukin-6 | 2 | 2019 | 3169 | 0.170 |
Why?
|
Nails | 1 | 2019 | 284 | 0.160 |
Why?
|
Health Occupations | 1 | 2018 | 217 | 0.150 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 646 | 0.150 |
Why?
|
Maternal Age | 1 | 2019 | 792 | 0.150 |
Why?
|
Prolactin | 1 | 2018 | 671 | 0.150 |
Why?
|
Hair | 1 | 2019 | 445 | 0.140 |
Why?
|
Hyperhomocysteinemia | 1 | 2016 | 124 | 0.140 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 272 | 0.140 |
Why?
|
Odds Ratio | 3 | 2019 | 9977 | 0.140 |
Why?
|
Ovariectomy | 1 | 2018 | 650 | 0.140 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 96 | 0.140 |
Why?
|
Male | 19 | 2022 | 350143 | 0.140 |
Why?
|
Nutrition Surveys | 4 | 2017 | 1586 | 0.140 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2021 | 1234 | 0.140 |
Why?
|
Sleep, REM | 1 | 2019 | 582 | 0.140 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 960 | 0.140 |
Why?
|
Pregnancy Trimesters | 1 | 2016 | 198 | 0.130 |
Why?
|
Flavones | 1 | 2014 | 63 | 0.130 |
Why?
|
Anthocyanins | 1 | 2014 | 68 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1482 | 0.130 |
Why?
|
Flavonols | 1 | 2014 | 79 | 0.130 |
Why?
|
Flavanones | 1 | 2014 | 77 | 0.130 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 510 | 0.130 |
Why?
|
Risk | 3 | 2017 | 9813 | 0.130 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2022 | 4014 | 0.120 |
Why?
|
Politics | 1 | 2020 | 771 | 0.120 |
Why?
|
Spine | 1 | 2020 | 1111 | 0.120 |
Why?
|
Insulin Infusion Systems | 1 | 2014 | 217 | 0.120 |
Why?
|
Mexican Americans | 1 | 2014 | 173 | 0.120 |
Why?
|
Anthropometry | 1 | 2018 | 1377 | 0.120 |
Why?
|
Feces | 1 | 2019 | 1373 | 0.120 |
Why?
|
Folic Acid | 2 | 2016 | 1254 | 0.120 |
Why?
|
Exercise | 2 | 2022 | 5428 | 0.110 |
Why?
|
Adolescent | 6 | 2022 | 85064 | 0.110 |
Why?
|
Environmental Exposure | 3 | 2023 | 4054 | 0.110 |
Why?
|
Pregnancy | 5 | 2017 | 27362 | 0.110 |
Why?
|
Glucose Intolerance | 1 | 2016 | 577 | 0.110 |
Why?
|
Neoplasms | 1 | 2021 | 20515 | 0.110 |
Why?
|
Pregnancy Trimester, First | 1 | 2016 | 838 | 0.110 |
Why?
|
Hysterectomy | 1 | 2018 | 902 | 0.110 |
Why?
|
Glucose Tolerance Test | 1 | 2015 | 1154 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2019 | 2767 | 0.110 |
Why?
|
Flavonoids | 1 | 2014 | 425 | 0.110 |
Why?
|
Estrogen Replacement Therapy | 1 | 2018 | 1185 | 0.110 |
Why?
|
Linear Models | 2 | 2019 | 5983 | 0.100 |
Why?
|
Sleep Apnea Syndromes | 1 | 2019 | 869 | 0.100 |
Why?
|
Physical Fitness | 1 | 2016 | 747 | 0.100 |
Why?
|
Body Weight | 2 | 2019 | 4689 | 0.100 |
Why?
|
Diet, Mediterranean | 1 | 2016 | 636 | 0.100 |
Why?
|
Wakefulness | 1 | 2017 | 1176 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5444 | 0.100 |
Why?
|
Environmental Monitoring | 2 | 2014 | 1372 | 0.100 |
Why?
|
Hypercholesterolemia | 1 | 2017 | 1159 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2022 | 72448 | 0.090 |
Why?
|
Brain | 1 | 2016 | 25189 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 1984 | 0.090 |
Why?
|
Anxiety | 2 | 2022 | 3912 | 0.090 |
Why?
|
Young Adult | 8 | 2022 | 56140 | 0.090 |
Why?
|
Reference Values | 1 | 2016 | 5046 | 0.090 |
Why?
|
Child | 4 | 2022 | 74413 | 0.080 |
Why?
|
Boston | 3 | 2016 | 9374 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12490 | 0.080 |
Why?
|
Diabetes, Gestational | 1 | 2016 | 1088 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2368 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2022 | 19529 | 0.080 |
Why?
|
Prognosis | 2 | 2019 | 28991 | 0.070 |
Why?
|
Weight Gain | 1 | 2016 | 2224 | 0.070 |
Why?
|
Logistic Models | 3 | 2016 | 13605 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2983 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2652 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2022 | 4276 | 0.070 |
Why?
|
Registries | 1 | 2019 | 8042 | 0.060 |
Why?
|
Weight Loss | 1 | 2014 | 2514 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58293 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 5914 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2015 | 2827 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6284 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2022 | 122 | 0.060 |
Why?
|
Aircraft | 1 | 2023 | 116 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 2777 | 0.050 |
Why?
|
Stroke | 2 | 2022 | 9504 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2022 | 199 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 21804 | 0.050 |
Why?
|
African Americans | 1 | 2016 | 4991 | 0.050 |
Why?
|
Blood Pressure | 1 | 2016 | 8534 | 0.050 |
Why?
|
Albumins | 1 | 2022 | 565 | 0.050 |
Why?
|
Tomography | 1 | 2021 | 361 | 0.050 |
Why?
|
Child, Preschool | 1 | 2022 | 41184 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13219 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 852 | 0.040 |
Why?
|
Horses | 1 | 2019 | 293 | 0.040 |
Why?
|
Work Schedule Tolerance | 1 | 2022 | 563 | 0.040 |
Why?
|
Hemoglobins | 1 | 2022 | 1504 | 0.040 |
Why?
|
Diethylhexyl Phthalate | 1 | 2016 | 74 | 0.040 |
Why?
|
Nutrition Assessment | 1 | 2019 | 721 | 0.040 |
Why?
|
Metabolome | 1 | 2023 | 871 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2018 | 15101 | 0.030 |
Why?
|
Meat | 1 | 2019 | 595 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 426 | 0.030 |
Why?
|
Immunoassay | 1 | 2018 | 764 | 0.030 |
Why?
|
Leisure Activities | 1 | 2016 | 304 | 0.030 |
Why?
|
Animals | 3 | 2022 | 169173 | 0.030 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2016 | 545 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23482 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2016 | 712 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2017 | 415 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 11956 | 0.030 |
Why?
|
Tea | 1 | 2014 | 259 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23705 | 0.030 |
Why?
|
Mothers | 1 | 2022 | 2021 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1596 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2580 | 0.030 |
Why?
|
Pregnant Women | 1 | 2016 | 504 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3491 | 0.030 |
Why?
|
Prenatal Care | 1 | 2017 | 1043 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17399 | 0.020 |
Why?
|
China | 1 | 2016 | 2234 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1835 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5793 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2355 | 0.020 |
Why?
|
Maternal Exposure | 1 | 2016 | 907 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2016 | 2030 | 0.020 |
Why?
|
Triglycerides | 1 | 2016 | 2579 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6498 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 6855 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40040 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6500 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4005 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8742 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2016 | 3140 | 0.020 |
Why?
|
Lung | 1 | 2021 | 9734 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9640 | 0.010 |
Why?
|
Concepts
(232)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(86)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_